跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Humalog Mix25 Kwikpen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Humalog Mix25 Kwikpen
Approved
STANDARD
Humalog Mix25 Kwikpen
Eli Lilly Italia S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7269e1c45cce5db4
Company
Eli Lilly Italia S.p.A.
Type
Standard
Approval Details
Approval Id
7269e1c45cce5db4
Drug Approval Philippines Name
Humalog Mix25 Kwikpen
Product Name
Humalog Mix25 Kwikpen
Registration Number
BR-957
Brand Name
Humalog Mix25 Kwikpen
Generic Name
Insulin Lispro (rDNA)
Dosage Form
Suspension for Injection (SC)
Dosage Strength
100 Units/mL (3.5 mg/mL) Suspension for Injection (SC) (25% Insulin Lispro Solution + 75% Insulin Lispro Protamine Suspension)
Manufacturer
Eli Lilly Italia S.p.A.
Importer
Zuellig Pharma Corporation
Issuance Date
25 October 2022
Expiry Date
25 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7269e1c45cce5db4
Type
Standard
Back to Philippines FDA Approvals